The risk of incident coronary heart disease among veterans with and without hiv and hepatitis C

Circulation: Cardiovascular Quality and Outcomes

Volumn 4, Issue 4, 2011, Pages 425-432

  Freiberg, Matthew S ^a,b   Chang, Chung Chou H ^a,b   Skanderson, Melissa ^c   McGinnis, Kathleen ^c   Kuller, Lewis H ^b   Kraemer, Kevin L ^a   Rimland, David ^d   Goetz, Matthew B ^e   Butt, Adeel A ^a,f   Rodriguez Barradas, Maria C ^g   Gibert, Cynthia ^h   Leaf, David ^e   Brown, Sheldon T ⁱ   Samet, Jeffrey ^j   Kazis, Lewis ^k   Bryant, Kendall ^l   Justice, Amy C ^c,m  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^l NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Comorbidity; Coronary disease; Mortality; Viruses

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG DEPENDENCE; EDUCATIONAL STATUS; ETHNICITY; EVALUATION AND FOLLOW UP; FEMALE; HEPATITIS C; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TREATMENT DURATION; VETERAN;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK; SURVIVAL ANALYSIS; VETERANS;

EID: 80054770309     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.110.957415     Document Type: Article

References (33)

1. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fatkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. Cd4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296 (Pubitemid 44837777)
2. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S. Coronary heart disease in HIV-infected individuals. J Acquir Immune Deficiency Synd (1999). 2003;33:506-512
3. Weber R, Sabin C, Reiss P, De Wit S, Law M, Dabis F, Monforte A, Fontas E, Lundgren J. Hepatitis virus co-infections and the risk of diabetes mellitus and myocardial infarctions in HIV-infected persons: The D:A:D study. 15th Conference on Retroviruses and Opportunistic Infections. 2008; February 3-6, Boston, M.A.
4. Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH. The association between hepatitis c infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS (London, England). 2007;21:193-197 (Pubitemid 46036927)
5. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010;11:462-468
6. Fultz SL, Skanderson M, Mole LA, Gandhi N, Bryant K, Crystal S, Justice AC. Development and verification of a "virtual" cohort using the national VA health information system. Med Care. 2006;44:S25-30 (Pubitemid 44284254)
7. Kazis LE, Nethercot CA, Ren XS, Lee A, Selim A, Miller DR. Medication effectiveness studies in the United States Veterans Administration Health Care System: A Model for large integrated delivery systems. Drug Development Research; 67:217-226
8. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med. 2006;166:1632-1641 (Pubitemid 44232373)
9. Kazis LE, Miller DR, Skinner KM, Lee A, Ren XS, Clark JA, Rogers WH, Iii AS, Selim A, Linzer M, Payne SM, Mansell D, Fincke BG. Applications of methodologies of the Veterans Health Study in the VA healthcare system: Conclusions and summary. J Ambul Care Manage. 2006;29:182-188 (Pubitemid 44481134)
10. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS (London, England). 2005;19(Suppl 3)S99-S105 (Pubitemid 41682176)
11. Petersen LA, Wright S, Normand SL, Daley J. Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med. 1999;14:555-558 (Pubitemid 29441635)
12. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S. Surveillance and ascertainment of cardiovascular events: The Cardiovascular Health Study. Ann Epidemiol. 1995;5: 278-285
13. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med. 2003;348:702-710 (Pubitemid 36237039)
14. Kraemer KL, McGinnis KA, Skanderson M, Cook R, Gordon A, Conigliaro J, Shen Y, Fiellin DA, Justice AC. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care. 2006;44:S44-S51 (Pubitemid 44284257)
15. Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Dominique C. Impact of specific NRTI and PI exposure on the risk of myocardial infarction: A case-control nested within FHDH ANRS CO4. Conference on Retroviruses and Opportunistic Infections. 2009; February 8-11, Montreal, Q.C.
16. Lundgren J, Reiss P, Worm S, Weber R, El-Sadr W, Wit SD, Law M, Monforte A, Pradier C, Sabin C, Aquatine A; ATHENA, INSIGHT, EuroSIDA, ICONA, Nice, SHCS, St Pierre Cohorts, and D:A:D Study Group. Risk of myocardial infarction with exposure to specific ARV from the PI, NNRTI, and NRTI drug classes: The D:A:D study. Conference on Retroviruses and Opportunistic Infections. 2009; February 8-11, Montreal, Q.C.
17. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526
18. Fine J, Gray RJ. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc. 1999;94:496-509
19. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55
20. Brubaker PH. Do not be statistically cenophobic: Time to ROC and roll! J Cardiopulm Rehabil Prev. 2008;28:420-421
21. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133: 592-599
22. Tomiyama H, Arai T, Hirose K, Hori S, Yamamoto Y, Yamashina A. Hepatitis C virus seropositivity, but not hepatitis b virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis. 2003;166:401-403 (Pubitemid 36071699)
23. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet. 2002;359: 133-135 (Pubitemid 34112545)
24. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA. 2003;289: 1245-1246 (Pubitemid 37432904)
25. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis c virus core protein and carotid atherosclerosis. Circ J. 2003;67:26-30 (Pubitemid 36119617)
26. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90:565-566 (Pubitemid 38530180)
27. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009;49:225-232
28. Momiyama Y, Ohmori R, Kato R, Taniguchi H, Nakamura H, Ohsuzu F. Lack of any association between persistent hepatitis B or C virus infection and coronary artery disease. Atherosclerosis. 2005;181: 211-213 (Pubitemid 40804713)
29. Volzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, Felix SB, John U. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004;174: 99-103 (Pubitemid 38595446)
30. Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis. 2006;43:e53-e56
31. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12:1365-1371 (Pubitemid 44924494)
32. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC. Human immunodeficiency virus-related microbial translocation and progression of hepatitis c. Gastroenterology. 2008;135:226-233 (Pubitemid 351899010)
33. Butt AA, Justice AC, Skanderson M, Rigsby MO, Good CB, Kwoh CK. Rate and predictors of treatment prescription for hepatitis C. Gut. 2007; 56:385-389. (Pubitemid 46579770)